Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04616183
Title	LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	rectum adenocarcinoma colon adenocarcinoma
Therapies	Abemaciclib + Cetuximab + LY3214996 Cetuximab + LY3214996
Age Groups:	senior \| adult
Covered Countries	USA